These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12640062)
1. Visible infarction on computed tomography is an independent predictor of poor functional outcome after stroke, and not of haemorrhagic transformation. Wardlaw JM; West TM; Sandercock PA; Lewis SC; Mielke O; J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):452-8. PubMed ID: 12640062 [TBL] [Abstract][Full Text] [Related]
2. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558 [TBL] [Abstract][Full Text] [Related]
3. Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials. Thompson DD; Murray GD; Candelise L; Chen Z; Sandercock PA; Whiteley WN Int J Stroke; 2015 Oct; 10(7):1024-30. PubMed ID: 25864571 [TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of visible infarction on computed tomography following lacunar stroke: results of a long-term follow-up study. Walters MR; Weir CJ; Adams FG; Lees KR J Neuroimaging; 2005 Oct; 15(4):331-5. PubMed ID: 16254397 [TBL] [Abstract][Full Text] [Related]
5. Visible infarction on CT after stroke--what does it tell? Kay R; Hui AC J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):413. PubMed ID: 12640050 [No Abstract] [Full Text] [Related]
7. CT angiography in acute stroke: does it provide additional information on occurrence of infarction and functional outcome after 3 months? Ritter MA; Poeplau T; Schaefer A; Kloska SP; Dziewas R; Ringelstein EB; Heindel W; Nabavi DG Cerebrovasc Dis; 2006; 22(5-6):362-7. PubMed ID: 16888376 [TBL] [Abstract][Full Text] [Related]
8. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. England TJ; Bath PM; Sare GM; Geeganage C; Moulin T; O'Neill D; Woimant F; Christensen H; De Deyn P; Leys D; Ringelstein EB; Stroke; 2010 Dec; 41(12):2834-9. PubMed ID: 21030711 [TBL] [Abstract][Full Text] [Related]
9. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065 [TBL] [Abstract][Full Text] [Related]
10. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis. Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320 [TBL] [Abstract][Full Text] [Related]
11. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Puetz V; Dzialowski I; Hill MD; Subramaniam S; Sylaja PN; Krol A; O'Reilly C; Hudon ME; Hu WY; Coutts SB; Barber PA; Watson T; Roy J; Demchuk AM; Int J Stroke; 2008 Nov; 3(4):230-6. PubMed ID: 18811738 [TBL] [Abstract][Full Text] [Related]
12. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet; 1997 Jun; 349(9066):1641-9. PubMed ID: 9186381 [TBL] [Abstract][Full Text] [Related]
13. The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST). Sare GM; Bath PM; Gray LJ; Moulin T; Woimant F; England T; Geeganage C; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB; Stroke; 2009 Jan; 40(1):41-6. PubMed ID: 18988907 [TBL] [Abstract][Full Text] [Related]
14. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke. D'Amelio M; Terruso V; Famoso G; Di Benedetto N; Realmuto S; Valentino F; Ragonese P; Savettieri G; Aridon P J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):649-54. PubMed ID: 23834850 [TBL] [Abstract][Full Text] [Related]
15. Association between hemorrhagic transformation after endovascular therapy and poststroke seizures. Thevathasan A; Naylor J; Churilov L; Mitchell PJ; Dowling RJ; Yan B; Kwan P Epilepsia; 2018 Feb; 59(2):403-409. PubMed ID: 29288487 [TBL] [Abstract][Full Text] [Related]
16. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595 [TBL] [Abstract][Full Text] [Related]
17. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
18. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase. Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S; J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309 [TBL] [Abstract][Full Text] [Related]
19. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke. Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533 [TBL] [Abstract][Full Text] [Related]